These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 7933669)

  • 21. [Clinical evaluation of N-acetyl-beta-D-glucosaminidase on prediction of diabetic nephropathy].
    Minakami H
    Hokkaido Igaku Zasshi; 1992 Mar; 67(2):234-46. PubMed ID: 1350771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of tranilast in early-stage diabetic nephropathy.
    Soma J; Sato K; Saito H; Tsuchiya Y
    Nephrol Dial Transplant; 2006 Oct; 21(10):2795-9. PubMed ID: 16820373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary concentration of transforming growth factor-beta-inducible gene-h3(beta ig-h3) in patients with Type 2 diabetes mellitus.
    Cha DR; Kim IS; Kang YS; Han SY; Han KH; Shin C; Ji YH; Kim NH
    Diabet Med; 2005 Jan; 22(1):14-20. PubMed ID: 15606685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of enalapril and nitrendipine on exercise albuminuria in normotensive type I diabetic patients with incipient nephropathy.
    Heinemann L; Janicke I; Bender R; Berger M; Sawicki PT
    Horm Metab Res; 1996 Oct; 28(10):549-52. PubMed ID: 8934214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
    Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Changes in blood pressure, proteinuria and renal hemodynamics in type I diabetes with manifestations of diabetic nephropathy after 2 months of captopril therapy].
    Komers R; Malý J; Simková R
    Cas Lek Cesk; 1993 Jun; 132(12):359-64. PubMed ID: 8343943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nephelometry in the clinical assessment of glomerular proteinuria and tubular function in diabetic nephropathy.
    Solerte SB; Severgnini S; Locatelli M; Cerutti N; Rondanelli M; Netti MA; Ferrari E; Fioravanti M
    Clin Nephrol; 1997 Sep; 48(3):151-8. PubMed ID: 9342486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical indicators which necessitate renal biopsy in type 2 diabetes mellitus patients with renal disease.
    Lin YL; Peng SJ; Ferng SH; Tzen CY; Yang CS
    Int J Clin Pract; 2009 Aug; 63(8):1167-76. PubMed ID: 18422591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of tissue inhibitors of metalloproteinase in diabetic nephropathy.
    Kanauchi M; Nishioka H; Nakashima Y; Hashimoto T; Dohi K
    Nihon Jinzo Gakkai Shi; 1996 Mar; 38(3):124-8. PubMed ID: 8721333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary albumin excretion in patients with non-insulin-dependent diabetes mellitus in an early microalbuminuric stage.
    Hotta O; Taguma Y; Mitsuoka M; Takeshita K; Takahashi H
    Nephron; 1991; 58(1):23-6. PubMed ID: 1857479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interrelations of blood pressure, glomerular filtration rate, protein clearances and sodium excretion in patients with glomerulonephritis and diabetic nephropathy.
    Ala-Houhala I; Oksa H; Pasanen M; Pasternack A
    Nephrol Dial Transplant; 1990; 5(5):337-41. PubMed ID: 2115624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The proteinuria of diabetic nephropathy.
    Jones RH; Marshall WJ; Myers RC; Watkins PJ; Parsons V
    Clin Chim Acta; 1980 Dec; 108(3):375-83. PubMed ID: 7008980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical significance of urinary acid-soluble protein in diabetic nephropathy].
    Kanauchi M; Sawai F; Hirayama T; Yumura F; Hamaguchi T; Nishiura K; Dohi K; Ishikawa H
    Nihon Jinzo Gakkai Shi; 1986 Oct; 28(10):1329-36. PubMed ID: 3820809
    [No Abstract]   [Full Text] [Related]  

  • 35. Transferrinuria in type 2 diabetic patients with early nephropathy and tubulointerstitial injury.
    Kanauchi M; Akai Y; Hashimoto T
    Eur J Intern Med; 2002 May; 13(3):190-193. PubMed ID: 12020627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined Detection of Urinary Micro Albumin, α1-microglobulin and N-acetyl-β-D-glucosaminidase in the Early Diagnosis of Diabetic Nephropathy.
    Zhang X; Zhou H; Li Y
    Pak J Med Sci; 2017; 33(6):1324-1327. PubMed ID: 29492052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exercise-induced proteinuria in diseases with metabolic disorders.
    Hidaka S; Kakuta S; Okada H; Chimata M; Nagase M
    Contrib Nephrol; 1990; 83():136-43. PubMed ID: 2100704
    [No Abstract]   [Full Text] [Related]  

  • 38. Urinary excretion of glycosaminoglycans in patients with early diabetic nephropathy.
    Pérez-Blanco F; Moreno-Terribas G; Cantero-Hinojasa J; Rodríguez-Cuartero A
    Nephron; 1996; 73(2):344-5. PubMed ID: 8773381
    [No Abstract]   [Full Text] [Related]  

  • 39. [Urine protein profile in healthy people following locomotor loading with changing intensity].
    Pastuchkova LKh; Fomina EV; Lysova NY; Kononikhin AS; Tiys ES; Larina IM
    Aviakosm Ekolog Med; 2015; 49(1):26-31. PubMed ID: 25958463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary excretion of frusemide and its metabolites in a diabetic nephropathy patient.
    Nakahama H; Orita Y; Izumi M; Fukuhara Y; Kamada T; Miwa Y; Yamaji A
    Eur J Clin Pharmacol; 1988; 35(1):113. PubMed ID: 3220093
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.